Survey: Consumers Divided on Whether Health Plans Are Partners or Payers

A recent study by HealthEdge highlights evolving consumer perceptions of health insurance, revealing both opportunities and challenges in how health plans are viewed and how digital tools—especially artificial intelligence (AI)—are shaping member engagement. The fifth annual Healthcare Consumer Report, based on a survey of over 4,500 U.S. health plan members, shows a notable shift in…

Motive Medical Intelligence Names Jay Sultan Executive Vice President of Product Strategy and Management

Motive Medical Intelligence has appointed Jay Sultan as Executive Vice President of Product Strategy and Management. The move adds a seasoned healthcare strategist to the company’s leadership team as it continues to evolve its data analytics offerings aimed at physician-level performance and value-based care. Leadership Role Focused on Product Strategy In his new role, Sultan…

Motive Medical Intelligence Launches Group-Level Clinical Reporting to Strengthen Value-Based Care

In a significant step toward improving performance transparency and enabling value-based care, Motive Medical Intelligence has launched Tax Identification Number (TIN)-level clinical performance measurement within its flagship platform, Practicing Wisely. Enhancing Group-Level Insights for Value-Based Contracts The new functionality addresses a critical gap in evaluating clinical performance at the group (TIN) level, offering healthcare organizations…

Withings in Partnership with French Government Invests €20.7M (~$22.5M USD) in AI and Technical Innovation

Withings Project DEEP is the winner of the i-démo call for projects under France 2030, operated by Bpifrance on behalf of the French Government Withings is taking a groundbreaking step toward reshaping preventative healthcare. Backed by an impressive €20.7 million (~$22.5M USD) investment and support from the French government through the France 2030 initiative, the…

Cured by Innovaccer Launches AI Capabilities to Create Intelligent, Personalized Healthcare Experiences

  Healthcare Experience AI is set to increase patient engagement, operational efficiency, and revenue growth while delivering personalized, proactive healthcare experiences Cured by Innovaccer, a healthcare experience platform, launched Healthcare Experience AI, a combination of next-generation AI capabilities blending generative and predictive AI to transform the patient experience. These capabilities are seamlessly integrated into the…

Socially Determined Advances Pediatric Healthcare by Providing New Visibility into Social Risks Impacting Minor Populations

  My Minors application gives Medicaid plans and other healthcare organizations data and insights to design and optimize programs that improve care and outcomes for children Socially Determined, the social risk analytics and solutions company leading the integration of health and social care, unveiled new capabilities that give healthcare organizations holistic visibility into the social…

| |

Better Health Secures $14 Million in Strategic Funding from Healthworx, University of Miami Health System and Mosaic General Partnership to Bring Medical Supply and Support Solutions to More Patients, Payers and Providers

  Investment from key healthcare leaders validates the Better Health care delivery model, bringing the company’s total funding to $27.5 million Better Health, a medical supply and support provider built on peer-to-peer connection, has secured $14 million in strategic funding, which includes investments from Healthworx, the innovation and investment arm of CareFirst Inc., UHealth –…

|

Oshi Health, the Nation’s First Virtual GI Center of Excellence, Announces 50 State Milestone

  Clinically proven, clinician-driven care accessible nationwide by September 2024 Oshi Health, a virtual healthcare clinic specializing in gastrointestinal (GI) care, will be available in all 50 states and the District of Columbia by September 2024. This milestone cements Oshi as the first virtual GI center of excellence with national scale, with in-network provider contracts…

Study Demonstrates MyPhenomeTM Hungry Gut Test Identifies Responders to Semaglutide

  New independent study’s findings presented during Presidential Plenary session at Digestive Disease Week 2024 Phenomix Sciences, a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has released an independent study led by Mayo Clinic and presented at Digestive Disease Week 2024 (DDW). The study demonstrates the clinical utility of the MyPhenomeTM Hungry…

Phenomix Sciences Raises $7.8M in Funding to Accelerate Adoption of Precision Medicine Focused on Obesity

  Precision medicine biotechnology company for obesity secures additional institutional capital from prominent industry leaders to expand the use of its novel phenotyping test and advance clinical research in weight loss treatment. Phenomix Sciences, a precision medicine biotechnology company that brings data intelligence to the treatment of obesity, has secured $5.5 million in Series A funding from…